The challenge of de-labeling penicillin allergy.
Elizabeth J PhillipsJason TrubianoDavid T ColemanChristine R F RukasinElizabeth J PhillipsPublished in: Allergy (2019)
Operationalizing penicillin allergy de-labeling as an aspect of ASP has become an increasing global focus. There is a need for validated approaches that optimally combine the use of history and ingestion challenge with or without proceeding formal skin testing to tackle penicillin allergy efficiently within complex healthcare systems. At the same time, there is great promise for penicillin allergy evaluation and de-labeling as an individual and public health strategy to reduce adverse healthcare outcomes, improve antimicrobial stewardship, and decrease healthcare costs.